INSR and neoplasm: Possible pathophysiology includes increased secretion of “big” IGF II which acts on insulin receptor, tumor invasion of liver, and adrenal glands blocking counterregulatory mechanisms to hypoglycemia, tumor producing insulin, and increased glucose utilization by the tumor and antibodies against insulin or insulin receptor.